Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients

Journal of Immunology

Volumn 170, Issue 4, 2003, Pages 2161-2169

  Meidenbauer, Norbert ^a   Marienhagen, Joerg ^a   Laumer, Monika ^a   Vogl, Sandra ^a   Heymann, Jana ^a   Andreesen, Reinhard ^a   Mackensen, Andreas ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; HLA A2 ANTIGEN; INDIUM 111; INTERLEUKIN 2; MELAN A; MUTANT PROTEIN; TETRAMER;

ADOPTIVE TRANSFER; ADVANCED CANCER; ANALYTIC METHOD; ARTICLE; CANCER IMMUNOTHERAPY; CELL SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; ISOTOPE LABELING; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MELANOMA; METASTASIS; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TUMOR LOCALIZATION;

EID: 0037442228     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.4.2161     Document Type: Article

References (46)

1. Walter, E. A., P. D. Greenberg, M. J. Gilbert, R. J. Finch, K. S. Watanabe, E. D. Thomas, and S. R. Riddell. 1995. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333:1038.
2. Papadopoulos, E. B., M. Ladanyi, D. Emanuel, S. Mackinnon, F. Boulad, M. H. Carabasi, H. Castro-Malaspina, B. H. Childs, A. P. Gillio, T. N. Small, et al. 1994. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N. Engl. J. Med. 330:1185.
3. Dazzi, F., and J. Goldman. 1999. Donor lymphocyte infusions. Curr. Opin. Hematol. 6:394.
4. Rosenberg, S. A. 2001. Progress in human tumor immunology and immunotherapy. Nature 411:380.
5. Boon, T., P. G. Coulie, and E. B. Van den Eynde. 1997. Tumor antigens recognized by T cells. Immunol. Today 18:267.
6. + hematopoietic progenitor cells. Int. J. Cancer 86:385.
7. + Melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy. Clin. Cancer Res. 6:1997.
8. Szmania, S., A. Galloway, M. Bruorton, P. Musk, G. Aubert, A. Arthur, H. Pyle, N. Hensel, N. Ta, L. Lamb, Jr., et al. 2001. Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers. Blood 98:505.
9. Yee, C., J. A. Thompson, P. Roche, D. R. Byrd, P. P. Lee, M. Piepkorn, K. Kenyon, M. M. Davis, S. R. Riddell, and P. D. Greenberg. 2000. Melanocyte destruction after antigen- specific immunotherapy of melanoma: direct evidence oft cell-mediated vitiligo. J. Exp. Med, 192:1637.
10. Altman, J. D., P. A. Moss, P. J. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94.
11. Yee, C., S. R. Riddell, and P. D. Greenberg. 2001. In vivo tracking of tumor-specific T cells. Curr. Opin. Immunol. 13:141.
12. + hematopoietic progenitor cells. Cancer Immunol. Immunother. 48:118.
13. Fisher, B., B. S. Packard, E. J. Read, J. A. Carrasquillo, C. S. Carter, S. L. Topalian, J. C. Yang, P. Yolles, S. M. Larson, and S. A. Rosenberg. 1989. Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma. J. Clin. Oncol. 7:250.
14. 111In-oxine labelling of tumour-cytotoxic macrophages generated in vitro from circulating blood monocytes: an in vitro evaluation. Nucl. Med. Commun. 16:357.
15. + tumor specific cytotoxic T lymphocytes from peripheral blood lymphocytes by in vitro stimulation with CD80-transfected autologous melanoma cells. Eur. Cytokine Network 10:329.
16. Salter, R. D., D. N. Howell, and P. Cresswell. 1985. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics 21:235.
17. + antigen-specific cytotoxic T lymphocytes after enrichment based on cytokine secretion: comparison with the MHC-tetramer technology. Scand. J. Immunol. 52:544.
18. Jonuleit, H., U. Kuhn, G. Muller, K. Steinbrink, L. Paragnik, E. Schmitt, J. Knop, and A. H. Enk. 1997. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 27:3135.
19. Mackensen, A., G. Carcelain, S. Viel, M. C. Raynal, H. Michalaki, F. Triebel, J. Bosq, and T. Hercend. 1994. Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J. Clin. Invest 93:1397.
20. Hoffmann, T. K., V. S. Donnenberg, U. Friebe-Hoffmann, E. M. Meyer, C. R. Rinaldo, A. B. DeLeo, T. L. Whiteside, and A. D. Donnenberg. 2000. Competition of peptide-MHC class I tetrameric complexes with anti-CD3 provides evidence for specificity of peptide binding to the TCR complex. Cytometry 41:321.
21. Mayer, S., C. Scheibenbogen, K. H. Lee, W. Keilholz, S. Stevanovic, H. G. Rammensee, and U. Keilholz. 1996. A sensitive proliferation assay to determine the specific T cell response against HLA-A2.1-binding peptides. J. Immunol. Methods 197:131.
22. Valmori, D., J. F. Fonteneau, C. M. Lizana, N. Gervois, D. Lienard, D. Rimoldi, V. Jongeneel, F. Jotereau, J. C. Cerottini, and P. Romero. 1998. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues. J. Immunol. 160:1750.
23. Pittet, M. J., A. Zippelius, D. E. Speiser, M. Assenmacher, P. Guillaume, D. Valmori, D. Lienard, F. Lejeune, J. C. Cerottini, and P. Romero. 2001. Ex vivo IFN-γ secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases. J. Immunol. 166:7634.
24. + T cells. J. Immunol. 165:2287.
25. Dutoit, V., V. Rubio-Godoy, M. A. Doucey, P. Batard, D. Lienard, D. Rimoldi, D. Speiser, P. Guillaume, J. C. Cerottini, P. Romero, and D. Valmori. 2002. Functional avidity of tumor antigen- specific CTL recognition directly correlates with the stability of MHC/peptide multimer binding to TCR. J. Immunol. 168: 1167.
26. Whiteside, T. L. 2002. Tumor-induced death of immune cells: its mechanisms and consequences. Semin. Cancer Biol. 12:43.
27. Lee, P. P., C. Yee, P. A. Savage, L. Fong, D. Brockstedt, J. S. Weber, D. Johnson, S. Swetter, J. Thompson, P. D. Greenberg, M. Roederer, and M. M. Davis. 1999. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat. Med. 5:677.
28. Lustgarten, J., J. Marks, and L. A. Sherman. 1999. Redirecting effector T cells through their IL-2 receptors. J. Immunol. 162:359.
29. + CTL reactive against tumor cells expressing a naturally occurring rejection epitope. J. Immunol. 167:4286.
30. Rosenberg, S. A., B. S. Packard, P. M. Aebersold, D. Solomon, S. L. Topalian, S. T. Toy, P. Simon, M. T. Lotze, J. C. Yang, and C. A. Seipp. 1988. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma: a preliminary report. N. Engl. J. Med. 319:1676.
31. Cerwenka, A., T. M. Morgan, and R. W. Dutton. 1999. Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial. J. Immunol. 163: 5535.
32. + melanoma patients by mature monocyte-derived dendritic cells. J. Immunol. 165:3492.
33. + T cells by endogenous tumor antigen and peptide vaccines: a comparison to virus-specific T cells. Eur. J. Immunol. 32:731.
34. + T cells in individuals receiving highly active antiretroviral therapy (HAART). J. Immunol. 162:1780.
35. Heslop, H. E., C. Y. Ng, C. Li, C. A. Smith, S. K. Loftin, R. A. Krance, M. K. Brenner, and C. M. Rooney. 1996. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat. Med. 2:551.
36. Mitchell, M. S., D. Darrah, D. Yeung, S. Halpern, A. Wallace, J. Voland, V. Jones, and J. Kan-Mitchell. 2002. Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope. J. Clin. Oncol. 20:1075.
37. Economou, J. S., A. S. Belldegrun, J. Glaspy, E. M. Toloza, R. Figlin, J. Hobbs, N. Meldon, R. Kaboo, C. L. Tso, A. Miller, et al. 1996. In vivo trafficking of adoptively transferred interleukin-2 expanded tumor-infiltrating lymphocytes and peripheral blood lymphocytes: results of a double gene marking trial. J. Clin. Invest 97:515.
38. + T cells specific for EBV in healthy virus carriers. J. Immunol. 162:1827.
39. Riddell, S. R., K. S. Watanabe, J. M. Goodrich, C. R. Li, M. E. Agha, and P. D. Greenberg. 1992. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257:238.
40. Dudley, M. E., J. Wunderlich, M. I. Nishimura, D. Yu, J. C. Yang, S. L. Topalian, D. J. Schwartzentruber, P. Hwu, F. M. Marincola, R. Sherry, et al. 2001. Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma. J. Immunother. 24:363.
41. Lee, K. H., E. Wang, M. B. Nielsen, J. Wunderlich, S. Migueles, M. Connors, S. M. Steinberg, S. A. Rosenberg, and F. M. Marincola. 1999. Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression. J. Immunol. 163:6292.
42. Whelan, J. A., P. R. Dunbar, D. A. Price, M. A. Purbhoo, F. Lechner, G. S. Ogg, G. Griffiths, R. E. Phillips, V. Cerundolo, and A. K. Sewell. 1999. Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent. J. Immunol. 163:4342.
43. Griffith, K. D., E. J. Read, J. A. Carrasquillo, C. S. Carter, J. C. Yang, B. Fisher, P. Aebersold, B. S. Packard, M. Y. Yu, and S. A. Rosenberg. 1989. In vivo distribution of adoptively transferred indium-111-labeled tumor infiltrating lymphocytes and peripheral blood lymphocytes in patients with metastatic melanoma. J. Natl. Cancer Inst. 81:1709.
44. Read, E. J., A. M. Keenan, C. S. Carter, P. S. Yolles, and R. J. Davey. 1990. In vivo traffic of indium-111-oxine labeled human lymphocytes collected by automated apheresis.J. Nucl. Med. 31:999.
45. de Jong, W. H., M. M. van de Plas, P. A. Steerenberg, W. Kruizinga, and E. J. Ruitenberg. 1985. Selective localization of tumor-immune spleen cells at the tumor challenge site after adoptive transfer of line 10 tumor immunity in strain 2 guinea pigs. J. Immunol. 134:2032.
46. Mule, J. J., F. R. Jones, I. Hellstrom, and K. E. Hellstrom. 1979. Selective localization of radiolabeled immune lymphocytes into syngeneic tumors. J. Immunol. 123:600.